Researchers Find No Clear Evidence of Self-Harm Risk From Antismoking Drug

By Salynn Boyles WebMD Health News Reviewed by Louise Chang, MD

Oct. 1, 2009 — The antismoking drug Chantix has been linked to suicide and suicidal thoughts, but a new study shows that if such a risk exists it is likely to be very small.

Researchers from the U.K.’s drug regulatory agency and the University of Bristol compared the incidence of suicide and self-harm among smokers taking Chantix to that of smokers using the drug Zyban or nicotine-replacement products to help them give up cigarettes.

Last July, the FDA announced it would require More >